NASDAQ
Acura Pharmaceuticals, Inc. (ACUR) has a free cash flow growth of -323.04% as of Friday, May 29, 2026. This represents a 4330.46% decrease compared to its 12-month average of 7.64%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.